US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Israel’s Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2025.

Trade group the Association of the British Pharmaceutical Industry (ABPI) has spoken out against a new free trade agreement signed by the UK government with India.

US President Donald Trump has signed an executive order attempting to restore a robust domestic manufacturing base for ...

A Seattle-based preclinical biotech comany developing novel neuroplastogens to treat neuropsychiatric and neurodegenerative ...

Sino American biotech BeiGene (Nasdaq: ONC; HKEX: 06160), a global oncology company that will change its name to BeOne ...

UK-based pharma major AstraZeneca and its Japanese partner Daiichi Sankyo are moving to expand the reach of their blockbuster ...

Shares in Danish drugmaker Novo Nordisk were 3% higher on Wednesday afternoon after the company presented its first-quarter ...

French drugmaker Ipsen (Euronext: IPN) today announced new data from two late-breaking presentations on Iqirvo (elafibranor) ...

NewLimit was founded to develop medicines that add healthy years to each human life. Initially, we thought it would take many ...

California-based Atara Biotherapeutics (Nasdaq: ATRA) revealed that the US Food and Drug Administration (FDA) has lifted the ...

Lossmaking Danish pharma ingredients maker Xellia Pharmaceuticals said it could only survive against Chinese competition by ...